Long-term effect of natalizumab in relapsing-remitting multiple sclerosis: TYSTEN cohort

被引：0
|
作者：
Bigaut, K. [1 ]
Fabacher, T. [2 ]
Kremer, L. [1 ]
Ongagna, J. -C. [1 ]
Kwiat-Kowski, A. [3 ]
Sellal, F. [4 ]
Ferriby, D. [5 ]
Courtois, S. [6 ]
Vermersch, P. [7 ]
Collongues, N. [1 ]
Zephir, H. [7 ]
De Seze, J. [1 ]
Outteryck, O. [7 ]
机构：
[1] Hop Univ Strasbourg, Dept Neurol, Strasbourg, France
[2] Hop Univ Strasbourg, Grp Methode Rech Clin, Strasbourg, France
[3] Grp Hop Inst Catholique Lille, Dept Neurol, Hop St Vincent, Lille, France
[4] Hop Civils Colmar, Dept Neurol, Colmar, France
[5] Ctr Hosp Tourcoing, Dept Neurol, Tourcoing, France
[6] Grp Hosp Reg Mulhouse & Sud Alsace, Dept Neurol, Mulhouse, France
[7] Ctr Hosp Reg Univ Lille, Dept Neurol, Lille, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1013
引用
收藏
页码：536 / 536
页数：1
相关论文
共 50 条
  • [31] Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
    Boster, Aaron L.
    Ford, Corey C.
    Neudorfer, Orit
    Gilgun-Sherki, Yossi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 575 - 586
  • [32] Interferons in relapsing-remitting multiple sclerosis -: Are there benefits from long-term use?
    Fernández, O
    CNS DRUGS, 2004, 18 (15) : 1057 - 1070
  • [33] Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [34] Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
    Melin, A.
    Outteryck, O.
    Collongues, N.
    Zephir, H.
    Fleury, M. C.
    Blanc, F.
    Lacour, A.
    Ongagna, J. C.
    Berteloot, A. S.
    Vermersch, P.
    de Seze, J.
    JOURNAL OF NEUROLOGY, 2012, 259 (06) : 1215 - 1221
  • [35] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, Chiara
    Roth, Serge
    Findling, Oliver
    Perriard, Guillaume
    Bachmann, Valerie
    Pless, Misha L.
    Baumann, Andreas
    Kamm, Christian P.
    Lalive, Patrice H.
    Czaplinski, Adam
    NEUROLOGY, 2017, 88
  • [36] Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
    A. Melin
    O. Outteryck
    N. Collongues
    H. Zéphir
    M. C. Fleury
    F. Blanc
    A. Lacour
    J. C. Ongagna
    A. S. Berteloot
    P. Vermersch
    J. de Sèze
    Journal of Neurology, 2012, 259 : 1215 - 1221
  • [37] Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis
    Cohen, Jeffrey
    Tenenbaum, Nadia
    Bhatt, Alit
    Pimentel, Ron
    Kappos, Ludwig
    NEUROLOGY, 2017, 89 (08) : E103 - E103
  • [38] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    NEUROLOGY, 2020, 94 (15)
  • [39] Cladribine vs Rituximab in Relapsing-Remitting Multiple Sclerosis: A Parallel Cohort Study on Comparative Long-Term Effectiveness
    Rod, Brit Ellen
    Hogestol, Einar A.
    Wergeland, Stig
    Bjornevik, Kjetil
    Gran, Jon Michael
    Overas, Mathias H.
    Konig, Marton
    Celius, Elisabeth G.
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    Nygaard, Gro
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 28 - 29
  • [40] Long-term follow-up of laquinimod in patients with relapsing-remitting multiple sclerosis
    Comi, G.
    Vollmer, T. L.
    Ashtamker, N.
    Sidi, Y.
    Ladkani, D.
    Gorfine, T.
    Sorensen, P. S.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 39 - 39
12345